[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
Sakamoto
M
M
Mikasa
K
K
Majima
T
T
Konishi
M
M
Maeda
K
K
Yoshimoto
E
E
Murakawa
K
K
Takahashi
K
K
Kita
E
E
Narita
N
N
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012189:Retrospective Studies
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D004917:Erythromycin